Coterra Energy: Still Trucking After Loss Of Harkey Wells
Seeking Alpha· 2025-08-18 12:20
Coterra Energy (NYSE: CTRA ) released earnings earlier this month, reporting $329 million in free cash flow despite falling crude and natural gas prices during the quarter. While this performance was down from a strong Q1, the company wasI am a Licensed Professional Engineer who works in the Nuclear Power industry. I use my professional working knowledge of the power/energy industries to aid in evaluating potential equities worthy of long-term investment. I invest in income producing equities and rental rea ...
VivoPower's Tembo e-LV Subsidiary on Track for $200 Million Enterprise Value Investment from Energi Holdings via SPAC Transaction
GlobeNewswire News Room· 2025-08-18 12:20
Energi to acquire 51% of Tembo with VivoPower continuing to hold a significant shareholding in Tembo post-SPAC merger Energi is supportive of Tembo’s business combination with Cactus Acquisition Corp 1 Limited (“SPAC”) at an equity valuation of $838 million Tembo can now resume finalizing and filing the F-4 SPAC Registration Statement LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR) (“VivoPower” or the “Company”) today announced it has reached agreement with Energi Holdi ...
KCE: Recent Outperformance Can Continue
Seeking Alpha· 2025-08-18 12:18
The SPDR S&P Capital Markets ETF (NYSEARCA: KCE ) is an ETF that seeks to track the S&P Capital Markets Select Industry Index. The fund, launched in November 2005, has an expense ratio of 0.35% and currently has net assets of $590Blue Chip Portfolios is an investment publication company focused on delivering investing insights on single stocks, ETFs, and CEFs. Blue Chip Portfolios is also the publisher of the Blue Chip Portfolio's Newsletter on BeehiivAnalyst’s Disclosure:I/we have a beneficial long positio ...
Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs
Newsfile· 2025-08-18 12:16
Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applicationsIrvine Labs progresses development of proprietary dehydration and packaging processes while preparing for next scheduled importToronto, Ontario--(Newsfile Corp. - August 18, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms an ...
Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.
GlobeNewswire News Room· 2025-08-18 12:16
Extrovis AGBahnhof Park 46340, Baar, SwitzerlandMedia Relations ContactMadhu Marurmadhu.marur@extrovis.com Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RD ...
Homeland Nickel Exploration Update at Red Flat and Property Acquisition
Thenewswire· 2025-08-18 12:15
Toronto, Ontario – TheNewswire - August 18, 2025 – Homeland Nickel Inc. (“Homeland Nickel” or the “Company”) (TSX-V: SHL, OTC: SRCGF) is pleased to announce it has received a Surface Use Determination (SUD) from the Forest Service regarding its proposed Plan of Operation to drill 44 sonic holes at its 100% wholly owned Red Flat Nickel Laterite Project (“Red Flat”), located in Southern Oregon, 12 kilometres inland from the community of Gold Beach. The Company has also staked several mining claims over known ...
One Very Overrated And One Very Underrated REIT
Seeking Alpha· 2025-08-18 12:15
Some REITs ( VNQ ) are very popular, and yet, they are severely overrated in my opinion. On the flip side, some smaller and lesser-known REITs are often underrated and deserve more attention.Your timing is perfect! We’ve just released our latest top investment picks for August 2025, and by joining today, you’ll gain immediate access to these exciting opportunities.We invest thousands of hours and over $100,000 annually into researching the most profitable investment opportunities—all to bring you real estat ...
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
Prnewswire· 2025-08-18 12:15
ENGLEWOOD, Colo., Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company. On June 30, 2025, the Company announced the Board's appointment of Steven Dyson as the incoming CEO. Since that time, Mr. Dyson and Tho ...
Arthur J. Gallagher & Co. Closes Acquisition of AssuredPartners
Prnewswire· 2025-08-18 12:14
ROLLING MEADOWS, Ill., Aug. 18, 2025 /PRNewswire/ -- Arthur J. Gallagher & Co. (NYSE: AJG) ("Gallagher") today announced it has closed the previously announced acquisition of AssuredPartners (the "Transaction"). "I am extremely excited to welcome our new colleagues to Gallagher," said J. Patrick Gallagher, Jr., Chairman and CEO. "Together, we will further build upon our client-centric, entrepreneurial cultures and utilize our product and industry expertise, extensive data, innovative analytical tools, outs ...
Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program
Thenewswire· 2025-08-18 12:10
Toronto, Ontario – TheNewswire - August 18, 2025 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”,) (TSXV:VPT; OTC:VPTDF) a leader in AI-powered heart analysis solutions, is pleased to announce the appointment of Thomas Brown, former Vice President of North American Sales at Intelligent Ultrasound, as Director of the Congenital Heart Defect (CHD) Program. Mr. Brown brings more than 20 years of leadership experience in global medical imaging sales, commercialization, and market expansion. ...